Storage conditions：Short-term storage at 2~8℃, long-term storage at -20 ~ -80℃
Berberine Sulfate (CAS number: 633-66-9) is a natural alkaloid isolated from the traditional Chinese medicine Coptis chinensis, belonging to the family of isoquinoline alkaloids. As a traditional Chinese medicine ingredient with a long history, berberine has attracted much attention due to its diverse pharmacological activities, especially in the fields of antibacterial, anti-inflammatory, anti-tumor, and metabolic regulation, showing significant potential. Berberine in sulfate form not only maintains the biological effects of its active ingredients, but also enhances its clinical feasibility by improving water solubility and bioavailability.
In recent years, with the rapid development of molecular pharmacology and natural product chemistry, the mechanism of action of berberine sulfate has gradually been revealed, especially in inducing the generation of reactive oxygen species (ROS), inhibiting DNA topoisomerase, and regulating various cellular signaling pathways, breakthrough progress has been made. In addition, the potential therapeutic value of berberine sulfate in neurological diseases such as migraine disorders has also attracted widespread attention, with its related targets involving various key molecules such as ALOX15, BCHE, ACHE, EDNRA, DRD1, ADRA1A, TAAR1, EP300, and P2RX7.
This article aims to systematically review the chemical structure and physicochemical properties, plant sources and extraction methods, pharmacological activity and mechanism of action, pharmacological evaluation and pharmacokinetic characteristics of berberine sulfate, and explore its prospects and challenges in clinical applications, providing scientific basis and theoretical support for subsequent research and development.
The chemical formula of berberine sulfate is C20H18NO4S, with a molecular weight of 431.42. Its structural core is an isoquinoline skeleton with multiple oxygen-containing functional groups and a sulfate anion. The molecular structure contains 9 hydrogen bond acceptors, which greatly affect its ability to bind with biomolecules. The LogP value is -0.66, indicating that it has strong hydrophilicity, which is closely related to its enhanced water solubility in sulfate form. The TPSA (topological polar surface area) is 119.89 Å ², indicating its high polarity. Typically, these compounds have weak cell membrane penetration ability.
The physicochemical properties of berberine sulfate determine its distribution and metabolic characteristics in the body. Its blood-brain barrier permeability is relatively low, indicating that its direct action in the central nervous system may be limited, but it can still exert neuroprotective and anti-inflammatory effects by regulating targets in the peripheral nervous and vascular systems. In addition, berberine sulfate exhibits cardiotoxicity and hERG channel inhibitory activity, indicating the need to pay attention to its potential cardiovascular safety issues in clinical applications.
Berberine sulfate mainly comes from the traditional Chinese medicine Coptis chinensis Franch., Phellodendron amurense Rupr., and other plants containing berberine. Huanglian, as an important traditional Chinese medicine herb for clearing heat and dampness, detoxifying and stopping diarrhea, is rich in berberine alkaloids in its roots and stems.
Traditional extraction methods usually use water or alcohol solvents for extraction, followed by separation and purification through processes such as acidification precipitation, alkaline reflux, and column chromatography. The application of modern extraction techniques such as ultrasound assisted extraction, microwave-assisted extraction, and high-performance liquid chromatography (HPLC) purification methods has improved extraction efficiency and purity. The preparation of sulfate forms is usually achieved by reacting berberine with sulfuric acid to form salts, enhancing its water solubility and stability, which facilitates the development of pharmaceutical formulations.
Berberine sulfate, as a traditional natural antibiotic product, has been widely reported to have inhibitory effects on various bacteria, fungi, and parasites. The mechanism mainly involves cell membrane disruption, inhibition of nucleic acid synthesis, and interference with energy metabolism. Research has shown that berberine sulfate has significant activity against both Gram positive and Gram negative bacteria, and exhibits a certain inhibitory effect on drug-resistant strains.
Berberine sulfate exhibits a wide range of anti-tumor effects by inducing intracellular reactive oxygen species (ROS) generation, triggering cell apoptosis and autophagy processes. It can inhibit DNA topoisomerase activity, block DNA replication and repair in tumor cells, leading to cell cycle arrest and death. In addition, berberine sulfate regulates multiple signaling pathways (such as PI3K/Akt, MAPK, NF - κ B, etc.), inhibiting tumor cell proliferation, migration, and invasion.
Although berberine sulfate has limited blood-brain barrier permeability, its regulatory effects on the peripheral nervous system and vascular system are significant. By inhibiting acetylcholinesterase (ACHE) and butyrylcholinesterase (BCHE), regulating neurotransmitter metabolism, and improving neurological dysfunction. At the same time, berberine sulfate has potential therapeutic value for migraines and other neurological diseases by regulating targets such as ALOX15, EDNRA, and DRD1, reducing inflammation and oxidative stress.
Berberine sulfate also plays an active role in the regulation of glucose and lipid metabolism, can improve insulin resistance, reduce blood sugar and lipid levels, and has potential anti diabetes and cardiovascular protection.
The pharmacological effects of berberine sulfate involve synergistic regulation of multiple targets and pathways, mainly including:
The comprehensive regulation of the above targets enables berberine sulfate to exhibit significant pharmacological activities in anti-tumor, neuroprotective, and anti-inflammatory aspects.
The molecular weight of berberine sulfate is 431.42, with a LogP of -0.66, indicating its strong hydrophilicity and high TPSA, suggesting limited cell membrane penetration. The low permeability of the blood-brain barrier limits the direct function of the central nervous system. The metabolic pathways in the body are not fully understood, but its hepatotoxicity is still uncertain and requires further systematic evaluation. Its cardiac toxicity and hERG channel inhibitory activity suggest potential risk of arrhythmia, and clinical application requires careful monitoring of cardiovascular safety.
The preparation of sulfate forms significantly improves its water solubility and bioavailability, enhancing oral absorption and drug efficacy. Pharmacokinetic studies have shown that berberine sulfate is widely distributed in the body, but has a fast metabolic rate and a short half-life, suggesting the need to optimize the dosing regimen to maintain effective blood drug concentrations.
Berberine sulfate, as a natural product with multiple targets and mechanisms, has broad clinical application potential. Its application prospects in anti infection, anti-tumor, neuroprotection, and metabolic disease treatment are highly anticipated. Especially in the treatment of migraine disorders, berberine sulfate can effectively alleviate vascular spasm and neuroinflammation by regulating multiple targets such as ALOX15, ACHE, and EDNRA, providing a new treatment approach.
However, the cardiac toxicity and hERG channel inhibition risk of berberine sulfate are the main obstacles to its clinical development, and its toxic side effects need to be reduced through structural modification, dosage form optimization, and combination therapy strategies. Meanwhile, in-depth pharmacokinetic and toxicological studies are key to promoting its clinical translation.
Future research should focus on:
Berberine sulfate, as a natural product with rich pharmacological activity, has demonstrated unique advantages in anti-tumor, neuroprotective, and anti infective fields due to its multi-target regulation and multiple biological effects. The development of its sulfate form effectively enhances water solubility and bioavailability, providing a solid foundation for clinical applications. Despite safety challenges such as cardiac toxicity, berberine sulfate is expected to become an important candidate for future natural drug development through scientific drug design and rational clinical strategies.
Based on current research progress, in-depth exploration of the mechanism and clinical translation of berberine sulfate will inject new vitality into the field of natural product pharmacology and promote its widespread application in modern medicine.
